Ad is loading...
NAOV
Price
$0.64
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
NURO
Price
$3.93
Change
+$0.14 (+3.69%)
Updated
Nov 15 closing price
Ad is loading...

NAOV vs NURO

Header iconNAOV vs NURO Comparison
Open Charts NAOV vs NUROBanner chart's image
NanoVibronix
Price$0.64
Change-$0.00 (-0.00%)
Volume$23.43K
CapitalizationN/A
NeuroMetrix
Price$3.93
Change+$0.14 (+3.69%)
Volume$2.99K
CapitalizationN/A
NAOV vs NURO Comparison Chart
Loading...
NAOV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NURO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NAOV vs. NURO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAOV is a Sell and NURO is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NAOV: $0.64 vs. NURO: $3.93)
Brand notoriety: NAOV and NURO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NAOV: 10% vs. NURO: 15%
Market capitalization -- NAOV: $1.8M vs. NURO: $8.07M
NAOV [@Medical Specialties] is valued at $1.8M. NURO’s [@Medical Specialties] market capitalization is $8.07M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAOV’s FA Score shows that 1 FA rating(s) are green whileNURO’s FA Score has 1 green FA rating(s).

  • NAOV’s FA Score: 1 green, 4 red.
  • NURO’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAOV and NURO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAOV’s TA Score shows that 5 TA indicator(s) are bullish while NURO’s TA Score has 5 bullish TA indicator(s).

  • NAOV’s TA Score: 5 bullish, 4 bearish.
  • NURO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NAOV is a better buy in the short-term than NURO.

Price Growth

NAOV (@Medical Specialties) experienced а -1.54% price change this week, while NURO (@Medical Specialties) price change was +5.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

NAOV is expected to report earnings on Mar 01, 2023.

NURO is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NURO($8.07M) has a higher market cap than NAOV($1.8M). NURO YTD gains are higher at: 9.164 vs. NAOV (-44.435). NAOV has higher annual earnings (EBITDA): -4.49M vs. NURO (-7.1M). NURO has more cash in the bank: 18M vs. NAOV (3.79M). NAOV has less debt than NURO: NAOV (19K) vs NURO (241K). NURO has higher revenues than NAOV: NURO (5.9M) vs NAOV (1M).
NAOVNURONAOV / NURO
Capitalization1.8M8.07M22%
EBITDA-4.49M-7.1M63%
Gain YTD-44.4359.164-485%
P/E RatioN/AN/A-
Revenue1M5.9M17%
Total Cash3.79M18M21%
Total Debt19K241K8%
FUNDAMENTALS RATINGS
NAOV vs NURO: Fundamental Ratings
NAOV
NURO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5657
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NURO's Valuation (27) in the Medical Specialties industry is in the same range as NAOV (30). This means that NURO’s stock grew similarly to NAOV’s over the last 12 months.

NURO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NAOV (100). This means that NURO’s stock grew similarly to NAOV’s over the last 12 months.

NURO's SMR Rating (95) in the Medical Specialties industry is in the same range as NAOV (97). This means that NURO’s stock grew similarly to NAOV’s over the last 12 months.

NAOV's Price Growth Rating (56) in the Medical Specialties industry is in the same range as NURO (57). This means that NAOV’s stock grew similarly to NURO’s over the last 12 months.

NAOV's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as NURO (100). This means that NAOV’s stock grew similarly to NURO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAOVNURO
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
NAOV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NURO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WFRD81.86-1.64
-1.96%
Weatherford International plc
AMBA56.92-1.58
-2.70%
Ambarella
HLVX1.83-0.06
-3.17%
HilleVax
FUBO1.51-0.06
-3.82%
fuboTV
TFFP0.38-1.24
-76.49%
TFF Pharmaceuticals

NAOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAOV has been loosely correlated with CLPT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NAOV jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAOV
1D Price
Change %
NAOV100%
+0.00%
CLPT - NAOV
33%
Loosely correlated
-2.76%
TTOO - NAOV
33%
Loosely correlated
-4.42%
CDNA - NAOV
31%
Poorly correlated
-1.76%
SENS - NAOV
31%
Poorly correlated
-0.18%
NARI - NAOV
30%
Poorly correlated
+2.68%
More

NURO and

Correlation & Price change

A.I.dvisor tells us that NURO and SGHT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURO and SGHT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURO
1D Price
Change %
NURO100%
+3.69%
SGHT - NURO
26%
Poorly correlated
-1.55%
NAOV - NURO
25%
Poorly correlated
+0.00%
MASI - NURO
23%
Poorly correlated
+0.57%
NVST - NURO
23%
Poorly correlated
+2.44%
DXR - NURO
23%
Poorly correlated
+2.15%
More